EU medicines agency to restrict use of Otsuka drug

LONDON (Reuters) - The European Medicines Agency said on Friday it was recommending restricting the use of medicines containing cilostazol, sold by Otsuka under the brand name Pletal, following concerns over side effects.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news